Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Global Biotechnologies, Inc.
WARNING LETTER
•Global Biotechnologies, Inc.•March 16, 2012

Global Biotechnologies, Inc. – FDA Warning Letter, Mar 16, 2012

Record Details

On August 21, 2012, the FDA issued a Warning Letter to Global Biotechnologies, Inc. following an inspection from January 25 to March 16, 2012. The inspection revealed significant violations of Current Good Manufacturing Practice (CGMP) regulations (21 CFR Part 111) for dietary supplements, rendering their Glucanol and Lactopril products adulterated under section 402(g)(1) of the Federal Food, Drug, and Cosmetic Act. The firm's March 30, 2012 response was deemed inadequate.

Key violations include: 1. **Failure to establish in-process specifications** for strength and composition in Master Manufacturing Records (MMRs), specifically for capsule weight (21 CFR 111.70(c)(1)). 2. **Failure to establish adequate component specifications** for identity, purity, strength, and composition of raw materials, such as gelatin capsules (21 CFR 111.70(b)). 3. **Failure to package and label as specified in the MMR**, evidenced by the lack of a written MMR for Glucanol dietary supplement packaging and labeling (21 CFR 111.415). 4. **Batch Production Records (BPRs) lacking complete information**, including equipment cleaning dates, unique component identifiers, component weights, actual/theoretical yields,

Company
Global Biotechnologies, Inc.
Inspection date
March 16, 2012
Product type
Food
Office
New England District Office
People
  • Mutahar Shamsi (District Director)
  • Anthony P. Costello (FOI Analyst)
View Company Profile

ID · 5906985a-e65d-48dd-9e5c-c015002548ff

Violation Codes10
21 CFR 11121 U.S.C. 342(g)(1)21 CFR 111.70(c)(1)21 CFR 111.7321 CFR 111.70(b)21 CFR 111.41521 CFR 111.255(b)21 CFR 111.26021 CFR 111.260(c)21 CFR 111.260(d)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Global Biotechnologies, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.